SCHEMBL20120002

SCHEMBL20120002

FC1(F)CC(COc2nc3c(NCc4ncco4)nc(Cl)nc3[nH]2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20119816 0.84 SMN1; SMN2 (0.45)
SCHEMBL20119500 0.81 HRH4 (0.32)
SCHEMBL20119898 0.80 SMN1; SMN2 (0.45)
SCHEMBL20119951 0.79
SCHEMBL20119944 0.71 SMN1; SMN2 (0.47)
SCHEMBL20119554 0.71 TRPM5 (0.31)
SCHEMBL20119784 0.71 SMN1; SMN2 (0.47)
SCHEMBL20119458 0.69 KDM4C (0.39)
SCHEMBL20119508 0.69 KDM4C (0.41)
SCHEMBL20119806 0.69 SMN1; SMN2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118748-A1 Compounds for Improving mRNA Splicing THE GENERAL HOSPITAL CORPORATION 2018-05-03 US disclosed